2018
DOI: 10.1093/ofid/ofy210.952
|View full text |Cite
|
Sign up to set email alerts
|

1119. Risk Factors for Clostridium difficile Acquisition and Persistence among Guatemalan Children

Abstract: BackgroundLittle is known about the epidemiology and risk factors for Clostridium difficile infection (CDI) among children in low and middle-income countries (LMICs). We sought to characterize the clinical, demographic, and environmental factors associated with C.difficile acquisition and persistence over time, and assess the relationship between CDI and additional diarrheal pathogens among rural and urban Guatemalan children.MethodsChildren 6–35 months old with acute nonbloody diarrhea (<72 hours) were enroll… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The recent transition from a narrow focus on individual organisms to polymicrobial carriage by the usage of multiplex PCR platforms bears important implications for emerging preventive and therapeutic approaches. The current challenge to determine the contribution of individual pathogens to diarrhoea makes treatment decisions difficult and might lead to over-utilization of antibiotics with adverse events and antimicrobial resistance [26]. Further technological refinement of such platforms is expected to significantly advance the field.…”
Section: Discussionmentioning
confidence: 99%
“…The recent transition from a narrow focus on individual organisms to polymicrobial carriage by the usage of multiplex PCR platforms bears important implications for emerging preventive and therapeutic approaches. The current challenge to determine the contribution of individual pathogens to diarrhoea makes treatment decisions difficult and might lead to over-utilization of antibiotics with adverse events and antimicrobial resistance [26]. Further technological refinement of such platforms is expected to significantly advance the field.…”
Section: Discussionmentioning
confidence: 99%